1.Dedong Yin#, Pan Wang#, Yongcun Hao#, Wei Yue#, Xinran Jiang#, Kuanming Yao, Yuqiong Wang, Xinxin Hang, Ao Xiao, Jingkun Zhou, Long Lin, Zhoulyu Rao, Han Wu, Feng Liu, Zaizai Dong, Meng Wu, Chenjie Xu, Jiandong Huang, Honglong Chang, Yubo Fan, Xinge Yu*, Cunjiang Yu*, Lingqian Chang*, Mo Li* . A battery-free nanofluidic intracellular delivery patch for internal organs, Nature, 2025, 642(8069):1051-1061.
2.Yuening Jiang, Jie Li, Tianzhen Wang, Xiaoyang Gu, Xinyu Li, Zhaofei Liu, Wei Yue*, Mo Li* . VIPAS39 confers ferroptosis resistance in epithelial ovarian cancer through exporting ACSL4, EBioMedicine, 2025, 114: 105646.
3.Taju Wu#, Fang Han#, Jinpei Mei, Jie Chen, Panpan Li, Mengyi Li, Jiaxin Shen, Xue Han, Rentian Song, Sainan Hou, Xinyu Li, Yutian Su*, Wei Yue*, Baohong Sun* . Photoactive metal-covalent organic framework nanozymes with enhanced peroxidase-mimicking activity for eliminating drug-resistant bacterial infections, J Colloid Interface Sci. 2025, 699(Pt 1):138178.
4.Wei Yue#, Xinyu Li#, Xiaolu Zhan#, Lei Wang, Jihong Ma, Meiyu Bi, Qilong Wang, Xiaoyang Gu, Bingteng Xie, Tong Liu, Hongyan Guo, Xin Zhu, Chen Song, Jie Qiao, Mo Li. PARP inhibitors suppress tumors via centrosome error-induced senescence independent of DNA damage response. EBioMedicine, 2024, 103:105129.
5.Wenjing Li, Guansheng Chen, Yongjun Wang, Yuening Jiang, Nanlin Wu, Mingjie Hu, Taju Wu*, Wei Yue* . Functional Analysis of BARD1 Missense Variants on Homology-Directed Repair in Ovarian and Breast Cancers, Molecular Carcinogenesis, 2024, 64(1): 91- 107.
6.Xinyu Li, Cuilian Zhang, Wei Yue*, and Yuening Jiang* . Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment. Frontiers in Immunology, 2024, 15: 1362120.
7.Yuening Jiang#, Wei Yue#, Meiyu Bi, Yuhan Guo, Xiaoyang Gu, Mo Li. Protocol for identifying metabolite biomarkers in uterine fluid for early ovarian cancer detection. STAR Protocols, 2024, 5(2): 102953.
8.Wei Yue, Jihong Ma, Yinan Xiao, Pan Wang, Xiaoyang Gu, Bingteng Xie, Mo Li. The apoptotic resistance of BRCA1-deficient ovarian cancer cells is mediated by cAMP. Frontiers in cell and developmental biology, 2022, 10:889656.
9.Bingteng Xie#, Xiaoling Liang#, Wei Yue#, Jihong Ma, Xinyu Li, Na Zhang, Pan Wang, Chang Liu, Xiaomeng Shi, Jie Qiao, Peng Zou, Mo Li. Targeting cytokinesis bridge proteins to kill high-CIN type tumors. Fundamental Research, 2021, 1(6):752-766.